Multiplex bead analysis of urinary cytokines of type 2 diabetic patients with normo- and microalbuminuria

Journal of Immunoassay and Immunochemistry

Volumn 31, Issue 4, 2010, Pages 279-289

  Liu, Jingfang ^a   Zhao, Zhenjun ^b   Willcox, Mark D P ^b   Xu, Banglao ^b   Shi, Bingyin ^a  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

chemokines; cytokines; diabetes; inflammation; microalbuminuria; normoalbuminuria

Indexed keywords

ALBUMIN; EOTAXIN; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALBUMINURIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; IMMUNOASSAY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; NORMOALBUMINURIA; PRIORITY JOURNAL; PROTEIN DETERMINATION;

ALBUMINURIA; CASE-CONTROL STUDIES; CYTOKINES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DIAGNOSTIC TECHNIQUES AND PROCEDURES; EARLY DIAGNOSIS; HUMANS; IMMUNOASSAY;

EID: 78649676150     PISSN: 15321819     EISSN: 15324230     Source Type: Journal    
DOI: 10.1080/15321819.2010.524860     Document Type: Article

References (29)

1. Ritz, E.; Orth, S.R. Nephropathy in patients with type 2 diabetes mellitus. N. Engl. J. Med. 1999, 341(15), 1127-1133.
2. Deckert, T.; Kofoed-Enevoldsen, A.; Norgaard, K.; Borch-Johnsen, K.; Feldt-Rasmussen, B.; Jensen, T. Microalbuminuria: Implications for micro-and macrovascular disease. Diabetes Care 1992, 15(9), 1181-1191.
3. Damsgaard, E.M.; Froland, A.; Jorgensen, O.D.; Mogensen, C.E. Microalbuminuria as a predictor of increased mortality in elderly people. BMJ 1990, 300(6720), 297-300.
4. Dalla Vestra, M.; Mussap, M.; Gallina, P.; Bruseghin, M.; Cernigoi, A.M.; Saller, A.; Plebani, M.; Fioretto, P. Acute-phase markers of inflammation and glomerular structure in patients with type 2 diabetes. J. Am. Soc. Nephrol. 2005, 16(Suppl 1), S78-S82.
5. Sassy-Prigent, C.; Heudes, D.; Mandet, C.; Bélair, M.F.; Michel, O.; Perdereau, B.; Bariéty, J.; Bruneval, P. Early glomerular macrophage recruitment in streptozotocin-induced diabetic rats. Diabetes 2000, 49(3), 466-475.
6. Furuta, T.; Saito, T.; Ootaka, T.; Soma, J.; Obara, K.; Abe, K.; Yoshinaga, K. The role of macrophages in diabetic glomerulosclerosis. Am. J. Kidney Dis. 1993, 21(5), 480-485.
7. Morii, T.; Fujita, H.; Narita, T.; Shimotomai, T.; Fujishima, H.; Yoshioka, N.; Imai, H.; Kakei, M.; Ito, S. Association of monocyte chemoattractant protein-1 with renal tubular damage in diabetic nephropathy. J. Diabetes Complications 2003, 17(1), 11-15.
8. Navarro-González, J.F.; Mora-Fernández, C. The role of inflammatory cytokines in diabetic nephro-pathy. J. Am. Soc. Nephrol. 2008, 19(3), 433-442.
9. Takebayashi, K.; Matsumoto, S.; Aso, Y.; Inukai, T. Association between circulating monocyte chemoattractant protein-1 and urinary albumin excretion in nonobese Type 2 diabetic patients. J. Diabetes Complications 2006, 20(20), 98-104.
10. Levey, A.S.; Bosch, J.P.; Lewis, J.B.; Greene, T.; Rogers, N.; Roth, D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann. Intern. Med. 1999, 130(6), 461-470.
11. Tashiro, K.; Koyanagi, I.; Saitoh, A.; Shimizu, A.; Shike, T.; Ishiguro, C.; Koizumi, M.; Funabiki, K.; Horikoshi, S.; Shirato, I.; Tomino, Y. Urinary levels of monocyte chemoattractant protein-1 (MCP-1) and interleukin-8 (IL-8), and renal injuries in patients with type 2 diabetic nephropathy. J. Clin. Lab. Anal. 2002, 16(1), 1-4.
12. Wang, Q.Y.; Chen, F.Q. Clinical significance and different levels of urinary monocyte chemoattrac-tant protein-1 in type 2 diabetes mellitus. Diabetes Res. Clin. Pract. 2009, 83(2), 215-219.
13. Wolkow, P.P.; Niewczas, M.A.; Perkins, B.; Ficociello, L.H.; Lipinski, B.; Warram, J.H.; Krolewski, A.S. Association of urinary inflammatory markers and renal decline in microalbuminuric type 1 diabetics. J. Am. Soc. Nephrol. 2008, 19(4), 789-797.
14. Shikano, M.; Sobajima, H.; Yoshikawa, H.; Toba, T.; Kushimoto, H.; Katsumata, H.; Tomita, M.; Kawashima, S. Usefulness of a highly sensitive urinary and serum IL-6 assay in patients diabetic nephropathy. Nephron 2000, 85(1), 81-85.
15. Navarro, J.F.; Mora, C.; Maca, M.; Garca, J. Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus. Am. J. Kidney Dis. 2003, 42(1), 53-61.
16. Banba, N.; Nakamura, T.; Matsumura, M.; Kuroda, H.; Hattori, Y.; Kasai, K. Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy. Kidney Int. 2000, 58(2), 684-690.
17. Wada, T.; Furuichi, K.; Sakai, N.; Iwata, Y.; Yoshimoto, K.; Shimizu, M.; Takeda, S.I.; Takasawa, K.; Yoshimura, M.; Kida, H.; Kobayashi, K.I.; Mukaida, N.; Naito, T.; Matsushima, K.; Yokoyama, H. Up-regulation of monocyte chemoattractant protein-1 in tubulointerstitial lesions of human diabetic nephropathy. Kidney Int. 2000, 58(4), 1492-1499.
18. Mora, C.; Navarro, J.F. Inflammation and pathogenesis of diabetic nephropathy. Metabolism 2004, 53(2), 265-266.
19. Ihm, C.G.; Park, J.K.; Hong, S.P.; Lee, T.W.; Cho, B.S.; Kim, M.J.; Cha, D.R.; Ha, H. A high glucose concentration stimulates the expression of monocyte chemotactic peptide 1 in human mesangial cells. Nephron 1998, 79(1), 33-37.
20. Prodjosudjadi, W.; Gerritsma, J.S.; Klar-Mohamad, N.; Gerritsen, A.F.; Bruijn, J.A.; Daha, M.R.; van Es, L.A. Production and cytokine-mediated regulation of monocyte chemoattractant protein-1 by human proximal tubular epithelial cells. Kidney Int. 1995, 48(5), 1477-1486.
21. Rovin, B.H.; Yoshiumura, T.; Tan, L. Cytokine-induced production of monocyte chemoattractant protein-1 by cultured human mesangial cells. J. Immunol. 1992, 148(7), 2148-2153.
22. Nakamura, T.; Fukui, M.; Ebihara, I.; Osada, S.; Nagaoka, I.; Tomino, Y.; Koide, H. mRNA expression of growth factors in glomeruli from diabetic rats. Diabetes 1993, 42(3), 450-456. (Pubitemid 23066522)
23. Kato, S.; Luyckx, V.A.; Ots, M.; Lee, K.W.; Ziai, F.; Troy, J.L.; Brenner, B.M.; MacKenzie, H.S. Renin-angiotensin blockade lowers MCP-1 expression in diabetic rats. Kidney Int. 1999, 56(3), 1037-1048.
24. Klein, R.; Klein, B.E.; Moss, S.E. Relation of glycemic control to diabetic microvascular complications in diabetes mellitus. Ann. Intern. Med. 1996, 124(1, Pt 2), 90-96.
25. Ha, H.; Yu, M.R.; Choi, Y.J.; Kitamura, M.; Lee, H.B. Role of high glucose-induced nuclear factor-kappaB activation in monocyte chemoattractant protein-1 expression by mesangial cells. J. Am. Soc. Nephrol. 2002, 13(4), 894-902.
26. Zhang, Z.; Yuan, W.; Sun, L.; Szeto, F.L.; Wong, K.E.; Li, X.; Kong, J.; Li, Y.C. 1,25-Dihydroxyvitamin D3 targeting of NF-kappaB suppresses high glucose-induced MCP-1 expression in mesangial cells. Kidney Int. 2007, 72(2), 193-201.
27. Wong, C.K.; Ho, A.W.; Tong, P.C.; Yeung, C.Y.; Kong, A.P.; Lun, S.W.; Chan, J.C.; Lam, C.W. Aberrant activation profile of cytokines and mitogen-activated protein kinases in type 2 diabetic patients with nephropathy. Clin. Exp. Immunol. 2007, 149(1), 123-131.
28. Wang, Y.; Chen, J.; Chen, L.; Tay, Y.C.; Rangan, G.K.; Harris, D.C. Induction of monocyte chemoat-tractant protein-1 in proximal tubule cells by urinary protein. J. Am. Soc. Nephrol. 1997, 8(10), 1537-1545.
29. Chen, H.B.; Lu, J.X.; Li, Q.; Bao, Y.Q.; Tang, J.L.; Lu, H.J.; Xiang, K.S.; Jia, W.P. The protective effect of the RAS inhibitor on diabetic patients with nephropathy in the context of VEGF suppression. Acta Pharmacol. Sin. 2009, 30(2), 242-250.